Day 1 - Friday, 17 November 2017
Meeting category
Date(s)
17 Nov 2017 - 18 Nov 2017
Location
Amsterdam,
Netherlands
Organizer
Platinum Level Support
Sponsor logos
International Viral Hepatitis Elimination Meeting (IVHEM) 2017
Related Enduring Materials
Enduring Materials
-
Setting the stage - Key challenges in elimination
Session 1: Test and screening strategies -
Chairs
Michael Ninburg
Hepatitis Education Project (HEP)
Maia Butshashvili, MD, MS, PhD
Health Research Union (HRU)
Global response to the strategic framework; Technologies perspective (not available)
Francesco Marinucci, PhD
FIND, Switzerland
Real-life experiences - USA (not available)
A. Blythe Ryerson, PhD MPH
Division of Cancer Prevention and Control, Atlanta, GA, USA
Session 2: Care & cure strategies -
Khin Pyone Kyi, MBBS, DBact, MMedSc, PhD, FRCP
Jeffrey V. Lazarus, PhD, MIH, MA
Chair
Jordan Feld, MD, MPH
Toronto Centre for Liver Disease, Canada
Manal El-Sayed, MD
Ain Shams University, Cairo, Egypt
Global trends in burden of disease
Graham Cooke, MD, PhD
Imperial College London, London, UK
Real-life experiences - bottlenecks & hurdles
Netherlands (not available)
Brazil
Australia
Myanmar
Ministry of Health, Myanmar; Ni Ni Diagnostics and Health Care Centre
Denmark
Barcelona Institute for Global Health (ISGlobal), Spain and CUNY Graduate School of Public Health and Health Policy, New York
Nigeria, sub-Saharan Africa
Pakistan
United States of America (not available)
A. Blythe Ryerson, MD, PhD
Division of Cancer Prevention and Control, Atlanta, GA, USA
Day 2 - Saturday, 18 November 2017
Session 3: Prevention & screening strategies -
Chair
Olufunmilayo Lesi, MD, MBA, FMCP, FWACP
University of Lagos, Nigeria; Honorary Consultant Gastroenterologist
Francesco Marinucci, PhD
FIND, Switzerland
Prevention transmission strategies on treatment - Pediatric population
Session 4: Innovative models to finance the health care problem -
Jeffrey V. Lazarus, PhD, MIH, MA
Chair
Margaret Hellard, AM, MBBS, FRACP, FAFPHM, PhD
Burnet Institute, Australia
Charles Boucher, MD, PhD
Erasmus Medical Center, the Netherlands
Medicines Patent Pool’s approach to scale up access to HIV and HCV treatment
Micro-elimination as a strategy to reach global elimination
Barcelona Institute for Global Health (ISGlobal), Spain and CUNY Graduate School of Public Health and Health Policy, New York
Overview
Welcome
IVHEM 2017 welcomed almost 70 participants from 22 different countries. The Program Committee would like to thank all invited speakers and participants for their valuable contribution to this workshop!
We would also like to thank our sponsors Gilead, Abbvie, and Mylan, for making this event possible and our meeting partners for their support.
Practical Information
Disclaimer
This meeting is intended for educational purposes only and aims to offer participants the opportunity to share information. The Organizing Secretariat of this meeting, Virology Education, cannot accept any liability for the scientific content of the sessions or for any claims which may result from the use of information or publications from this meeting.
Virology Education disclaims all liability for injuries or losses of whatever nature incurred by individuals attending the meeting.
Virology Education disclaims all liability for injuries or losses of whatever nature incurred by individuals attending the meeting.
Liability and Insurance
By registering for the meeting participants agree that the organizers do not accept responsibility for medical-, travel- or personal insurance. Participants are advised to take out their own insurance policies.
Committees
Program Committee
The members of the Program Committee (PC) discuss on a frequent basis the scientific program of the workshop, identify interesting topics and candidate speakers and review all submitted abstracts.
Scientific Committee
The members of Scientific Committee advise the Program Committee by providing them with suggestions for speakers and topics. In addition, members of the Scientific Committee participate in reviewing submitted abstracts, and act as an ambassador of the meeting.
Isabelle Andrieux-Meyer Drugs for Neglected Diseases Initiative, Geneva, Switzerland
Maia Butsashvili Health Research Union, Tblisi, Georgia
Graham Cooke Imperial College London, London, UK
Emalie Huriaux US National Viral Hepatitis Roundtable, Project Inform, San Francisco, CA, USA
Achim Kautz Leberhilfe Projekt gUG, Cologne, Germany
Khin Pyone Kyi Myanmar Liver Foundation, Rangoon, Myanmar
Ying-Ru Lo WHO Western Pacific Regional Office, Manilla, Philippines
Francesco Marinucci FIND, Geneva, Switzerland
Ponsiano Ocama Makerere University College of Health Sciences, Kampala, Uganda
Homie Razavi Center for Disease Analysis (CDA) , Louisville, CO, USA
Anya Sarang Andrey Rylkov Foundation for Health and Social Justice, Moscow, Russia
Wendy Spearman University of Cape Town, Cape Town, South Africa
Mark ThurszImperial College London, London, UK
Stefan Zeuzem J.W. Goethe University Hospital, Frankfurt, Germany
Rosmawati Mohamed University of Malaya, Kuala Lumpur, Malaysia
Evaldo Stanislau Affonso Araújo University of São Paulo Hospital das Clínicas Infectious Diseases Division, São Paulo, Brazil
Jude Byrne Australian Injecting & Illicit Drug Users League (AIVL), Canberra, Australia
Andrea Cox Johns Hopkins School of Medicine, Baltimore, MD, USA
Kenneth Kabagambe The National Organization for People Living with Hepatitis B (NOPLHB), Makere, Uganda
Shiv Kumr Sarin Institute of Liver and Biliary Sciences, Delhi, India
Jeffrey Lazarus CHIP, Copenhagen, Denmark
Liudmyla Maistat Medicines Patent Pool, Geneva, Switzerland
Shruti Mehta Johns Hopkins School of Medicine, Baltimore, MD, USA
Jean-Michel Pawlotsky Hôpital Henri Mondor , Paris, France
Tatjana Reic European Liver Patients Association, Brussels, Belgium
Marcelo Silva Austral University Hospital, Buenos Aires, Argentina
Lara Strick Washington Department of Corrections & University of Washington, Tumwater & Seattle, WA, USA
Imam Waked National Liver Institute, Shebeen El-Kom, Egypt
Huma Qureshi Pakistan Medical Research Council, Islamabad, Pakistan
Philippa Easterbrook World Health Organization, Geneva, Switzerland
Support
Platinum Level
Contributor
Meeting Partners
Local Meeting Partners
Endorsers
Language
Related Programs
